Environmental pharmacology: source, impact and solution

  title={Environmental pharmacology: source, impact and solution},
  author={Monalisa Jena and Archana Mishra and Rituparna Maiti},
  journal={Reviews on Environmental Health},
  pages={69 - 79}
Abstract Environmental pharmacology is the knowledge, study and the methods implemented for amalgamating the presence of pharmaceutical products and their metabolites in the environment. Pharmaceutical and house care products and their metabolites gain access to the environment through various means and affect the flora and fauna and modulate the ecosystem. The effect on wildlife, biofilms and human are being studied to gain knowledge of sources and causations. Potential risks of development of… 


Do Biological Medicinal Products Pose a Risk to the Environment?
The fate and the potential environmental impact of biological medicinal products following clinical use from an ecopharmacovigilance point of view are discussed, and relevant policy documents and regulatory statements are reviewed.
Human Pharmaceuticals in the Aquatic Environment a Review
Abstract There has been increasing concern in recent years about the occurrence, fate and toxicity of pharmaceutical products in the aquatic environment. Many of the more commonly used drug groups
Occurrence, fate and effects of pharmaceutical substances in the environment--a review.
Present knowledge does not reveal if regular therapeutic use may be the source of a substance carried by sewage effluent into the aquatic system, even though clofibrate, a lipid lowering agent, has been identified in ground and tap water samples from Berlin.
The Afterlife of Drugs and the Role of PharmEcovigilance
An overview of the occurrence of APIs as environmental pollutants, their ramifications for human health and the environment and some of the ways in which their impact could be reduced or minimized is provided.
Pharmaceuticals in the environment: expected and unexpected effects on aquatic fauna
  • E. Fabbri
  • Biology, Medicine
    Annals of the New York Academy of Sciences
  • 2015
Examples are presented of expected effects related to the therapeutic mode of action, unwanted/side effects mainly related to oxidative stress, and unexpected effects induced by environmental concentrations of pharmaceuticals in aquatic animals, demonstrating how pharmaceuticals behave differently from conventional pollutants.
Ecotoxicology of human pharmaceuticals.
It is shown that only very little is known about long-term effects of pharmaceuticals to aquatic organisms, in particular with respect to biological targets, and targeted ecotoxicological studies are needed focusing on subtle environmental effects.
Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies.
Results demonstrate room for improvement in areas such as the use of threshold values to trigger investigations, chronic and mechanism specific toxicity screening and mixture toxicity for which possible solutions are proposed.
Review of Antimicrobial Resistance in the Environment and Its Relevance to Environmental Regulators
It is argued that the lack of environment-facing mitigation actions included in existing AMR action plans is likely a function of the authors' poor fundamental understanding of many of the key issues and the science to inform policy is lacking and this needs to be addressed.
Pollution from drug manufacturing: review and perspectives
  • D. Larsson
  • Business, Medicine
    Philosophical Transactions of the Royal Society B: Biological Sciences
  • 2014
I contrast environmental pollution due to manufacturing with that due to excretion in terms of their risks and management and highlight some recent initiatives.
Beyond the medicine cabinet: an analysis of where and why medications accumulate.
The processes, actions, and behaviors that control and drive the consumption, accumulation, and need for disposal of pharmaceuticals are defined and an overview of the diverse locations where drugs are used and accumulate is provided.